<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
    <link rel="stylesheet" href="../css/uswds.min.css">
    <link rel="stylesheet" href="../css/style.css">
    <link rel="stylesheet" href="css/uswds.min.css">
    <link rel="stylesheet" href="css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/html/parts/21CFR341.html">Part 341
                                </a><span>&nbsp/&nbsp<span>
                                Sec.  341.20  Nasal decongestant active ingredients.
                            </h3>
                            <p class="depth0">The active ingredient of the product consists of any of the following when used within the dosage limits and in the dosage forms established for each ingredient:</p><p class="depth0"><em>(a)</em> Oral nasal decongestants. (1) Phenylephrine hydrochloride.</p><p class="depth0"><em>(2)</em> Pseudoephedrine hydrochloride.</p><p class="depth0"><em>(3)</em> Pseudoephedrine sulfate.</p><p class="depth0"><em>(4)</em> Phenylephrine bitartrate in an effervescent dosage form.</p><p class="depth0"><em>(b)</em> Topical nasal decongestants. (1) Levmetamfetamine.</p><p class="depth0"><em>(2)</em> Ephedrine.</p><p class="depth0"><em>(3)</em> Ephedrine hydrochloride.</p><p class="depth0"><em>(4)</em> Ephedrine sulfate.</p><p class="depth0"><em>(5)</em> [Reserved]</p><p class="depth0"><em>(6)</em> Naphazoline hydrochloride.</p><p class="depth0"><em>(7)</em> Oxymetazoline hydrochloride.</p><p class="depth0"><em>(8)</em> Phenylephrine hydrochloride.</p><p class="depth0"><em>(9)</em> Propylhexedrine.</p><p class="depth0"><em>(10)</em> Xylometazoline hydrochloride.
[59 FR 43409, Aug. 23, 1994, as amended at 63 FR 40650, July 30, 1998; 71 FR 43362, Aug. 1, 2006]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>. Code available <a href="#">on Github.</a></h5>
      </div>
    </div>
  </footer>
  </body>
</html>
